Statistics
Total Visits
| Views | |
|---|---|
| Phase I trial of 6-hour infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: A study of the European Organization for Research and Treatment of Cancer Early Clinical Studies Group | 128 |
Total Visits Per Month
| March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | |
|---|---|---|---|---|---|---|---|
| Phase I trial of 6-hour infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: A study of the European Organization for Research and Treatment of Cancer Early Clinical Studies Group | 3 | 0 | 1 | 4 | 0 | 5 | 1 |
Top country views
| Views | |
|---|---|
| Poland | 62 |
| United States | 44 |
| China | 7 |
| France | 4 |
| Sweden | 4 |
| Germany | 2 |
| Ireland | 2 |
| Australia | 1 |
| India | 1 |
Top cities views
| Views | |
|---|---|
| Warsaw | 62 |
| Boardman | 7 |
| San Ramon | 7 |
| San Diego | 5 |
| Ann Arbor | 4 |
| Beijing | 4 |
| San Mateo | 4 |
| Des Moines | 3 |
| Mountain View | 3 |
| Dublin | 2 |